Sort
21,453 grants matching “tuberculosis”
High-throughput identification of common CD8+ T cell responses to SIV and M. tuberculosis in rhesus macaques
$682,211David H Oconnor · University Of Wisconsin-Madison · R24 · FY2021 · OD
Imaging signatures of early tuberculosis
$682,110Yingda Linda Xie · Rutgers Biomedical And Health Sciences · R01 · FY2024 · AI
Redefining Tuberculosis Meningitis with Metagenomics and Host Transciptomics
$682,045Michael R Wilson · University Of California, San Francisco · R01 · FY2023 · AI
ART Adherence: Observed Therapy and Enhanced Counseling
$682,026University Of Missouri Kansas City · R01 · FY2004 · MH
Patient reported outcomes in patients with nontuberculous mycobacterial pulmonary disease
$682,008Emily M. Henkle · Oregon Health & Science University · R01 · FY2025 · HL
Epidemiology of Helicobacter Pylori Transmission
$681,962Julie Parsonnet · Stanford University · R01 · FY2008 · AI
Hollow Fiber Infection Model to Delineate Combination Drug Interaction for Different MTB Metabolic Populations and using Different Pharmacokinetic Profiles
$681,864George Louis Drusano · University Of Florida · P01 · FY2017 · AI
Technology Core - The Center for Innovation in Point-of-Care Technologies for HIV/AIDS and Emerging Infectious Diseases at Northwestern University (C-THAN)
$681,849Sally M McFall · Northwestern University · U54 · FY2025 · EB
Estimation of risk associated with zoonotic tuberculosis in South India
$681,791Vivek Kapur · Pennsylvania State University, The · R01 · FY2024 · AI
AIDS Clinical Trial Group Laboratory Center
$681,736Grace M. Aldrovandi · University Of California Los Angeles · UM1 · FY2025 · AI
The Warburg effect and host immune response in tuberculosis
$681,641Lanbo Shi · Rbhs-New Jersey Medical School · R01 · FY2021 · AI
Systems Biology
$681,422Rafick-Pierre Sekaly · Beth Israel Deaconess Medical Center · U19 · FY2015 · AI
The Bring BPaL2Me Trial - Comparing Nurse-Led RR-TB Treatment in Primary Care to Physician-Led, Hospital-Based RR-TB Treatment: A Cluster Randomized, Non-Inferiority Trial
$681,271Jason Edward Farley · Johns Hopkins University · R01 · FY2024 · AI
Optimization of Atypical Antimycobacterial Carbapenem Antibiotics
$681,269John D Buynak · Southern Methodist University · R01 · FY2025 · AI
Innate-adaptive crosstalk in protective and vaccine-induced immunity to TB
$681,243Jyothi Rengarajan · Emory University · R01 · FY2020 · AI
Microbial Diversity in Mechanisms of Disulfide Bond Formation and Reduction
$681,211Dana Boyd · Harvard Medical School · R01 · FY2013 · GM
Heme oxygenase-1 and the bioenergetic threshold of latent TB and HIV co-infection
$680,876Adrie Jc Steyn · University Of Alabama At Birmingham · R01 · FY2016 · AI
Investigating bacterial contributions to TB treatment response: a focus on in-host pathogen dynamics
$680,731Maha Farhat · Harvard Medical School · R01 · FY2023 · AI
OPTIMIZING HIV/TB MANAGEMENT IN THE HAART ERA
$680,703University Of Miami School Of Medicine · D43 · FY2004 · TW
Molecular Analysis of Host Immune Response in Leprosy
$680,666Robert L Modlin · University Of California Los Angeles · R01 · FY2019 · AI
ART Adherence: Observed Therapy and Enhanced Counseling
$680,406University Of Missouri Kansas City · R01 · FY2005 · MH
Canadian Fluoroscopy Cohort Study: Lifespan Mortality and Incidence Follow-Up
$680,242Lydia B Zablotska · University Of California, San Francisco · R01 · FY2017 · CA
Improved understanding of TB transmission by accounting for within-host heterogeneity of M. tuberculosis: A population-based molecular epidemiology study in a high HIV prevalent setting
$680,027Sanghyuk Sam Shin · University Of California-Irvine · R01 · FY2020 · AI
Testing of a Novel Inhaled Clofazimine (CFZ) Dry Powder Formulation in a Mouse Model of Mycobacterium tuberculosis
$680,009Janice Endsley · University Of Texas Med Br Galveston · N01 · FY2023 · AI
High-throughput identification of common CD8+ T cell responses to SIV and M. tuberculosis in rhesus macaques
$679,885David H Oconnor · University Of Wisconsin-Madison · R24 · FY2022 · OD